Atlas Trials

Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B

Clinical trial NCT02283671 · COMPLETED

Trial details

NCT number
NCT02283671
Sponsor
Sara Varea
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple SclerosisNeuromyelitis Optica
Start date
2015-09-01
Primary completion
2019-07-10
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.